CUAMC
DNLI icon

China Universal Asset Management Company’s Denali Therapeutics DNLI Stock Holding History

China Universal Asset Management Company’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Sell
29,819
-10,824
-27% -$222K 0.05% 229
2026
Q1 		$780K Buy
40,643
+16,745
+70% +$333K 0.06% 220
2025
Q4 		$395K Sell
23,898
-1,731
-7% -$29.2K 0.03% 280
2025
Q3 		$372K Sell
25,629
-3,549
-12% -$51K 0.03% 276
2025
Q2 		$408K Buy
29,178
+50
+0.2% +$704 0.04% 255
2025
Q1 		$396K Sell
29,128
-1,389
-5% -$26.6K 0.04% 263
2024
Q4 		$622K Buy
30,517
+2,982
+11% +$76.3K 0.06% 222
2024
Q3 		$802K Buy
27,535
+10,782
+64% +$267K 0.09% 159
2024
Q2 		$389K Sell
16,753
-9,968
-37% -$191K 0.05% 168
2024
Q1 		$548K Buy
26,721
+10,740
+67% +$202K 0.07% 175
2023
Q4 		$343K Buy
15,981
+12,455
+353% +$247K 0.07% 166
2023
Q3 		$72.7K Buy
3,526
+1,732
+97% +$43.9K 0.02% 213
2023
Q2 		$52.9K Sell
1,794
-57
-3% -$1.6K 0.02% 187
2023
Q1 		$42.6K Buy
1,851
+471
+34% +$13K 0.01% 160
2022
Q4 		$38.4K Buy
1,380
+225
+19% +$6.7K 0.02% 145
2022
Q3 		$35K Buy
+1,155
New +$37.5K 0.01% 132

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's DNLI Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Denali Therapeutics (DNLI) stake by 27% in Q2 2026, selling an estimated $222K and leaving 29,819 shares worth $767K. The position accounts for 0.05% of the portfolio, ranked #229.

China Universal Asset Management Company first reported a position in DNLI in Q3 2022 and has held it in 16 quarters since. The position peaked at $802K in Q3 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • China Universal Asset Management Company held 29,819 shares of Denali Therapeutics worth $767K as of Q2 2026.
  • China Universal Asset Management Company sold 10,824 Denali Therapeutics shares in Q2 2026, an estimated $222K.
  • Denali Therapeutics made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #229 holding.
  • China Universal Asset Management Company first reported a position in Denali Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Denali Therapeutics position peaked at $802K in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.